Continue reading about off-target effects in this story. Base and Prime Editing Offer Precision CRISPR-based systems that rely on traditional Cas nucleases like Cas9 cut through both strands of DNA ...

Prime editing allows precise changes to be made to DNA. A new way of editing the code of life could correct 89% of the errors in DNA that cause disease, say US scientists. The technology ...

Prime Medicine has been given the go-ahead by the FDA for the first human trial of its prime editing technology, which promises to deliver one-shot therapies for a range of severe genetic diseases.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

to initiate trials of the first-ever prime editing drug. The FDA cleared Prime Medicine’s investigational new drug (IND) application for PM359 for the treatment of chronic granulomatous disease ...

Prime Medicine, Inc. (NASDAQ:PRME) is a biotechnology company pioneering the field of gene editing with its Prime Editing technology. This next-generation technology allows precise and flexible ...

Gene-editing biotech Prime Medicine has priced a follow-on public offering, hoping to raise $140 million to advance its pipeline of one-shot therapies for severe genetic disorders. The Cambridge ...

Cas9-mediated tools are the foundation of CRISPR technologies, setting the stage for new generation base editors and prime editors, and opening the door to genome editing therapeutics with greater ...